Biomea Fusion, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Biomea Fusion, Inc. (BMEA) is 95.47M

According to Biomea Fusion, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 95.47M. This represents a change of 75.72% compared to the average of 54.33M of the last 4 quarters.

Biomea Fusion, Inc. (BMEA) Historical Enterprise Value (quarterly & annually)

How has BMEA Enterprise Value performed in the past?

The mean historical Enterprise Value of Biomea Fusion, Inc. over the last ten years is 129.17M. The current 95.47M Enterprise Value has changed 7.29% with respect to the historical average. Over the past ten years (40 quarters), BMEA's Enterprise Value was at its highest in in the March 2023 quarter at 844.52M. The Enterprise Value was at its lowest in in the March 2022 quarter at -23597647.52.

Biomea Fusion, Inc. (BMEA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biomea Fusion, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biomea Fusion, Inc. (BMEA) Average Enterprise Value

How has BMEA Enterprise Value performed in the past?

The current Enterprise Value of Biomea Fusion, Inc. (BMEA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Biomea Fusion, Inc. (BMEA) Enterprise Value vs. Peers

How is BMEA’s Enterprise Value compared to its peers?

Biomea Fusion, Inc.’s Enterprise Value is greater than Repare Therapeutics Inc. (41.75M), less than Cibus, Inc. (136.73M), greater than Immunic, Inc. (-13548475.00), less than Fractyl Health, Inc. (107.33M), greater than Unicycive Therapeutics, Inc. (83.84M), greater than CAMP4 Therapeutics Corporation (842.10K), less than ALX Oncology Holdings Inc. (221.16M), greater than PMV Pharmaceuticals, Inc. (65.61M), less than Adverum Biotechnologies, Inc. (159.14M), less than Sutro Biopharma, Inc. (106.25M),

Build a custom stock screener for Biomea Fusion, Inc. (BMEA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biomea Fusion, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biomea Fusion, Inc. (BMEA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biomea Fusion, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.